Continuous Renal Replacement Therapy Clinical Trial
Official title:
No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation
Do no monitor of post-circuit ionized calcium affact the filter life time of continueous renal replacement therapy with regional citrate anticoagulation circuit? A randomized control trial
Regional citrate anticoagulation is the gold standard of anticoagulation in patient receiving CRRT. In RCA circuit, there was a monitoring of pre-filter (systemic) ionized calcium and post-filter (circuit) ionized calcium. Pre-filter ionized calcium was monitored for observe the adverse effect of citrate such as hypocalcemia, citrate intoxication. However, post-filter ionized calcium was monitored for adjustment the citrate dose. We find many problem with frequently monitoring of post-ionized calcium such as confusion from markedly abnormal result, how to adjustment the citrate dose ,and increase workload for nurses. We hypothesis that if we can monitoring of post-filter ionized calcium? ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04537975 -
C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19
|
N/A | |
Recruiting |
NCT02034448 -
CRRTNet Registry- A Prospective Observational Registry
|
N/A | |
Recruiting |
NCT04114747 -
Renal Physiology During Continuous Renal Replacement Therapy
|
N/A | |
Withdrawn |
NCT04103307 -
Continuous Renal Replacement Therapy for Acute Kidney Injury by Cooling Blood
|
Phase 2 | |
Not yet recruiting |
NCT04315623 -
RCA for CRRT in Hyperlactatemia Patient With Increased Bleeding Risk
|
N/A | |
Recruiting |
NCT05450185 -
Filter Lifespan in Continuous Renal Replacement Therapy
|
||
Recruiting |
NCT06021080 -
Effects of Different Continuous Renal Replacement Therapy Patterns on Ionized Calcium in Patients With Citrate Anticoagulants Using Calcium-containing Replacement Solutions
|
||
Not yet recruiting |
NCT06369064 -
Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patient
|
N/A | |
Not yet recruiting |
NCT06425289 -
Macrohemodynamic Impact of Fluid Removal With Net Ultrafiltration in Patients With Continuous Renal Replacement Therapy
|
||
Completed |
NCT04959110 -
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT
|
N/A | |
Recruiting |
NCT03897582 -
Beta-Lactams Dosing In Pneumonia in ICU in Patients Treated by Continuous Renal Replacement Therapy: the BLIPIC Study
|
||
Recruiting |
NCT03144349 -
Diagnosis Accuracy of Hemoconcentration to Detect Hypovolemia During CRRT
|
||
Completed |
NCT04071171 -
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation
|
Phase 2 | |
Completed |
NCT03314363 -
Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
|
N/A | |
Completed |
NCT01405092 -
Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)
|
N/A |